These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5072650)

  • 1. Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.
    Tovi D; Nilsson IM; Thulin CA
    Acta Neurol Scand; 1972; 48(4):393-402. PubMed ID: 5072650
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
    Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
    Fodstad H; Nilsson IM
    Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruptured intracranial aneurysms.
    Neil-Dwyer G; Sharp MM
    J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):878-9. PubMed ID: 6619903
    [No Abstract]   [Full Text] [Related]  

  • 7. What about medical therapy alone?
    Check W
    JAMA; 1978 Nov; 240(20):2136. PubMed ID: 702712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic changes in subarachnoid hemorrhage and anti-fibrinolytic therapy--application of an anti-plasmin agent (t-AMCHA)].
    Watanabe H; Ishii S; Chigasaki H
    Nihon Rinsho; 1978; 36(3):555-62. PubMed ID: 650932
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.
    Tovi D
    Acta Neurol Scand; 1973; 49(2):163-75. PubMed ID: 4718188
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.
    Smith RR; Upchurch JJ
    J Neurosurg; 1973 Mar; 38(3):339-44. PubMed ID: 4268202
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
    Tovi D
    Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
    [No Abstract]   [Full Text] [Related]  

  • 13. Tranexamic acid in subarachnoid hemorrhage. A double-blind study.
    Kaste M; Ramsay M
    Stroke; 1979; 10(5):519-22. PubMed ID: 505491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

  • 15. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose tranexamic acid combined with aprotinin in the pre-operative management of ruptured intracranial aneurysms.
    Spallone A; Pastore FS; Rizzo A; Guidetti B
    Neurochirurgia (Stuttg); 1987 Nov; 30(6):172-6. PubMed ID: 2447515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
    Fodstad H; Pilbrant A; Schannong M; Strömberg S
    Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous thrombosis of ruptured intracranial aneurysm during treatment with tranexanic acid. Case report.
    Tanghetti B; Capra R; Marini G
    J Neurosurg Sci; 1985; 29(2):105-8. PubMed ID: 4093796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
    Fodstad H; Kok P; Algers G
    Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.